Group One Trading
ICPT

Group One Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Group One Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-95,000
Closed -$1.76M – 8455
2023
Q3 		$1.76M Sell
95,000
-29,100
-23% -$329K 0.01% 1749
2023
Q2 		$1.37M Buy
124,100
+52,400
+73% +$730K ﹤0.01% 2052
2023
Q1 		$963K Sell
71,700
-174,400
-71% -$3.02M ﹤0.01% 2172
2022
Q4 		$3.04M Sell
246,100
-78,600
-24% -$1.11M 0.01% 1482
2022
Q3 		$4.53M Buy
324,700
+32,100
+11% +$517K 0.01% 1239
2022
Q2 		$4.04M Buy
292,600
+185,100
+172% +$2.96M 0.01% 1460
2022
Q1 		$1.75M Sell
107,500
-88,300
-45% -$1.38M ﹤0.01% 2532
2021
Q4 		$3.19M Buy
195,800
+39,800
+26% +$671K ﹤0.01% 2118
2021
Q3 		$2.32M Buy
156,000
+64,300
+70% +$1.03M ﹤0.01% 2502
2021
Q2 		$1.83M Buy
91,700
+28,800
+46% +$571K ﹤0.01% 2752
2021
Q1 		$1.45M Sell
62,900
-91,400
-59% -$2.55M ﹤0.01% 2800
2020
Q4 		$3.81M Buy
154,300
+46,600
+43% +$1.54M 0.01% 1499
2020
Q3 		$4.46M Sell
107,700
-1,800
-2% -$82.7K 0.01% 994
2020
Q2 		$5.25M Sell
109,500
-1,300
-1% -$100K 0.02% 777
2020
Q1 		$6.98M Sell
110,800
-85,500
-44% -$7.68M 0.06% 384
2019
Q4 		$24.3M Buy
196,300
+90,900
+86% +$8.14M 0.17% 108
2019
Q3 		$6.99M Sell
105,400
-8,500
-7% -$571K 0.06% 416
2019
Q2 		$9.06M Sell
113,900
-48,700
-30% -$4.36M 0.08% 258
2019
Q1 		$18.2M Buy
162,600
+102,200
+169% +$11.2M 0.2% 81
2018
Q4 		$6.09M Buy
60,400
+8,800
+17% +$912K 0.05% 426
2018
Q3 		$6.52M Buy
51,600
+36,100
+233% +$3.82M 0.05% 458
2018
Q2 		$1.3M Buy
15,500
+7,500
+94% +$549K 0.01% 1464
2018
Q1 		$492K Sell
8,000
-84,700
-91% -$5.1M 0.01% 2083
2017
Q4 		$5.42M Sell
92,700
-30,800
-25% -$1.94M 0.04% 599
2017
Q3 		$7.17M Buy
123,500
+118,100
+2,187% +$12.7M 0.07% 375
2017
Q2 		$654K Sell
5,400
-1,800
-25% -$209K 0.01% 1767
2017
Q1 		$814K Sell
7,200
-8,100
-53% -$946K 0.01% 1483
2016
Q4 		$1.66M Buy
15,300
+13,300
+665% +$1.58M 0.02% 1023
2016
Q3 		$329K Sell
2,000
-3,600
-64% -$568K ﹤0.01% 2131
2016
Q2 		$799K Sell
5,600
-2,700
-33% -$394K 0.01% 1392
2016
Q1 		$1.07M Buy
8,300
+6,700
+419% +$791K 0.02% 1129
2015
Q4 		$239K Sell
1,600
-800
-33% -$135K ﹤0.01% 2373
2015
Q3 		$398K Buy
2,400
+1,600
+200% +$352K 0.01% 1966
2015
Q2 		$193K Sell
800
-16,500
-95% -$4.39M ﹤0.01% 2540
2015
Q1 		$4.88M Buy
17,300
+12,600
+268% +$2.73M 0.08% 265
2014
Q4 		$733K Buy
4,700
+4,200
+840% +$776K 0.01% 1273
2014
Q3 		$118K Sell
500
-400
-44% -$102K ﹤0.01% 2845
2014
Q2 		$213K Sell
900
-11,400
-93% -$3M ﹤0.01% 2350
2014
Q1 		$4.06M Buy
+12,300
New +$4.15M 0.07% 304

Group One Trading's ICPT Position: Q4 2023 in Review

Group One Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 53,694 shares — an estimated $995K sold.

Group One Trading first reported a position in ICPT in Q1 2014 and held it in 24 quarters. The position peaked at $3.6M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Group One Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 53,694 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $995K.
  • Group One Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 24 quarters.
  • Group One Trading's Intercept Pharmaceuticals, Inc. position peaked at $3.6M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.